Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Ropivacaine for post-operative pain in total shoulder replacement
NCT03739021Phase 3Not yet recruiting
- Sponsor
- University of South Florida
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of bupivacaine extended release liposome injection in postoperative pain, sponsored by University of South Florida. Primary endpoint: Duration of Surgery. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03739021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03739021.